SOLICITATION NOTICE
66 -- Parks Model 2100-SX-2 Computerized Flo-Lab
- Notice Date
- 9/2/2016
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- NHLBI-CSB-HL-2016-300-KMA
- Archive Date
- 9/24/2016
- Point of Contact
- Kevin Alvarez,
- E-Mail Address
-
kevin.alvarez@nih.gov
(kevin.alvarez@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION. The National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA), intends to negotiate and award a purchase order on a noncompetitive sole source basis to Parks Medical Electronics, Inc., 19460 SW Shaw St, Beaverton, OR, 97078-1242, to procure a Parks Model 2100-SX-2 Computerized Flo-Lab that will be shared between the Clinical Service and the Center of Molecular Medicine (CMM). BACKGROUND The Boehm Lab's research interests are to identify and better understand the molecular mechanisms underlying human vascular diseases and to develop new therapeutic approaches. Studies of patients with rare monogenetic vascular diseases are pivotal for understanding human vascular pathophysiology and have significant implications for comprehending more common complex, polygenetic vascular diseases. The diverse human research programs at the NIH provide a unique opportunity to study patients having monogenetic diseases with vascular implications. The Boehm Lab established the Patient-Centered Vascular Translational Program to conduct research on clinically relevant questions focused on vascular injury, remodeling, and repair, and to translate research findings into developing new therapeutic strategies. The aims of the Vascular Translational Program align with the principles of Precision Medicine, investigating how individual variations in genes, environment, and lifestyle contribute to vascular disease. This program was designed to link high-throughput sequencing data with molecular disease mechanisms to facilitate the development of targeted therapies for patients with vascular disorders. New clinical protocols developed for this program include comprehensive clinical evaluations, collection of human biospecimens for diagnostic and research purposes, and a first-in-humans treatment study. PURPOSE The purpose of this acquisition is to purchase a Parks Model 2100-SX-2 Computerized Flo-Lab system that will be shared between the Clinical Service and the Center of Molecular Medicine (CMM). This system will replace the current machine being used, a Parks Flo-Lab 2100 which is over 10 years old and no longer supported by the manufacturer. This new system will be used as part of an ongoing research project by CMM's Dr. Manfred Boehm. The overall mission of Dr. Boehm's study is to identify whether therapeutic interventions will improve peripheral arterial flow in research subjects (patients) with rare vascular diseases. This equipment is critical to the study as it will be used to measure the flow of blood through peripheral arteries and can also determine if these arteries have blockages. PROCUREMENT The contractor shall provide the following: •Parks Model 2100-SX-2 Computerized Flo-Lab JUSTIFICATION Through the market research performed, we have determined that Parks Medical Electronics is the only vendor currently manufacturing a vascular diagnostic instrument that meets the Government's research need. Parks has not authorized any third-party resellers to offer this equipment. In addition, until recently the lab has used a Parks Flo-Lab 2100 to perform procedures under the aforementioned clinical protocol. It is imperative that the lab purchase a similar machine in order to maintain continuity and integrity of the data. REGULATORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulations (FAR) Subpart 13.106-1(b), soliciting from a single source (for purchases not exceeding the simplified acquisition threshold) and only one responsible source and no other supplies or services will satisfy agency requirements. ADDITIONAL INFORMATION Industry Classification (NAICS) Code is 334516, Analytical Laboratory Instrument Manufacturing, and the Small Business Size Standard is 1000 employees. The acquisition is being conducted under FAR Part 13, Simplified Acquisition Procedures, therefore the requirements of FAR Part 6, Competitive Requirements, are not applicable (FAR Part 6.001). The resultant award will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 05-89 (August 15th, 2016). This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by September 9, 2016 at 9:00AM EST and must reference synopsis number NHLBI-CSB-HL-2016-300-KMA. Responses shall be submitted to the National Heart, Lung, and Blood Institute, Office of Acquisitions, COAC Services Branch, 6701 Rockledge Drive, Room 6127, Bethesda, Maryland 20892-7902, Attention: Kevin Alvarez. Responses may be submitted electronically to kevin.alvarez@nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NHLBI/NHLBI-CSB-HL-2016-300-KMA/listing.html)
- Record
- SN04253953-W 20160904/160902235012-d6d1ed2c66a55b7ce5d92ba90d48db30 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |